Encorafenib Plus Binimetinib for People With BRAF V600 Mutated Relapsed/Refractory HCL
Abroad (travel likely)RecruitingPHASE2
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Hairy Cell Leukemia
Locations
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States